Supports laboratory optimization and clinical validation of cancer biomarkers and assays using human samples to address defined clinical needs; clinical trials are not allowed.
NCI supports research on how biospecimen collection, processing, and storage affect biomarkers, aiming to standardize handling and improve clinical assay development; clinical trials are not allowed.
NIH supports investigator-initiated observational or biomarker validation studies requiring prospective collection or continued analysis of data or biospecimens; clinical trials are not allowed.
This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.
This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.